K. Kawanishi, Human species-specific loss of CMP-N-acetylneuraminic acid hydroxylase enhances atherosclerosis via intrinsic and extrinsic mechanisms, Proc. Natl. Acad. Sci. U.S.A, vol.116, pp.16036-16045, 2019.

T. Pham, Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium, Blood, vol.114, pp.5225-5235, 2009.

L. and L. Berre, Elicited and pre-existing anti-Neu5Gc antibodies differentially affect human endothelial cells transcriptome, Xenotransplantation, vol.26, p.12535, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02337077

S. Kavaler, Pancreatic beta-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency, FASEB J, vol.25, pp.1887-1893, 2011.

D. N. Kwon, CMP-Neu5Ac hydroxylase null mice as a model for studying metabolic disorders caused by the evolutionary loss of Neu5Gc in humans, BioMed Res. Int, p.830315, 2015.

A. Salama, Neu5Gc and ?1-3 GAL xenoantigen knockout does not affect glycemia homeostasis and insulin secretion in pigs, Diabetes, vol.66, pp.987-993, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01856314

D. A. Fontaine and D. B. Davis, Attention to background strain is essential for metabolic research: C57BL/6 and the International Knockout Mouse Consortium, Diabetes, vol.65, pp.25-33, 2016.

S. A. Schreyer, T. C. Lystig, C. M. Vick, and R. C. Leboeuf, Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity, Atherosclerosis, vol.171, pp.49-55, 2003.

A. Salama, Anti-Gal and anti-Neu5Gc responses in nonimmunosuppressed patients after treatment with rabbit antithymocyte polyclonal IgGs, Transplantation, vol.101, pp.2501-2507, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02156016

R. Amon, Glycan microarray reveal induced IgGs repertoire shift against a dietary carbohydrate in response to rabbit anti-human thymocyte therapy, Oncotarget, vol.8, pp.112236-112244, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01885572